Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
310.2 INR | +3.99% | -1.48% | -21.51% |
22/05 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
21/05 | Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.51% | 33Cr | |
+42.60% | 75TCr | |
+34.11% | 61TCr | |
-6.39% | 36TCr | |
+18.56% | 33TCr | |
+6.33% | 29TCr | |
+18.08% | 25TCr | |
-3.44% | 21TCr | |
+11.35% | 21TCr | |
+2.12% | 17TCr |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q3 2023 Earnings Call, Jan 24, 2023